Results 121 to 130 of about 20,435 (278)

Using isotonic magnesium sulfate nebulization as an adjuvant treatment for moderate acute exacerbation of bronchial asthma (aeba) in adult comparing with salbutamol alone: a double blinded, randomised control trial [PDF]

open access: yes, 2015
Objective The aim of this study is to evaluate the efficacy of single dose nebulized magnesium sulfate in augmenting bronchodilatory effect of salbutamol in acute asthma as compare to salbutamol alone.
Ket Keong, Liew
core  

Reducing cholinergic constriction: the major reversible mechanism in COPD

open access: yesEuropean Respiratory Review, 2006
The airway narrowing in chronic obstructive pulmonary disease (COPD) has often been misunderstood as being irreversible. However, a large proportion of patients with COPD do respond to bronchodilator agents with significant changes in lung function ...
V. Brusasco
doaj  

Randomised controlled trial of azithromycin in smokers with asthma [PDF]

open access: yes, 2013
Anderson, K.   +13 more
core   +2 more sources

Methacholine challenge testing: comparative pharmacology

open access: yesJournal of Asthma and Allergy, 2018
Beth E Davis, Christianne M Blais, Donald W Cockcroft Division of Respirology, Critical Care and Sleep Medicine, Department of Medicine, University of Saskatchewan, Saskatoon, SK, Canada Abstract: Standardization of the methacholine inhalation challenge,
Davis BE, Blais CM, Cockcroft DW
doaj  

Modelling the health related benefits of environmental policies and their feedback effects, a CGE analysis for the EU countries with GEM-E3 [PDF]

open access: yes
A number of recent studies on taxation in the presence of externalities in a second-best framework consider the implications of taking into account the feedback effects of environmental quality.
Denise Van Regemorter, Inge Mayeres
core  

Acute bronchodilator responses to β2-agonist and anticholinergic agent in COPD: Their different associations with exacerbation

open access: bronze, 2017
Satoshi Konno   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy